JPS55160721A - Pulmonary surfactant ta-546, its preparation, and remedy for pulmonary hyaline membrane syndrome comprising it as active constituent - Google Patents

Pulmonary surfactant ta-546, its preparation, and remedy for pulmonary hyaline membrane syndrome comprising it as active constituent

Info

Publication number
JPS55160721A
JPS55160721A JP6821179A JP6821179A JPS55160721A JP S55160721 A JPS55160721 A JP S55160721A JP 6821179 A JP6821179 A JP 6821179A JP 6821179 A JP6821179 A JP 6821179A JP S55160721 A JPS55160721 A JP S55160721A
Authority
JP
Japan
Prior art keywords
pulmonary
surfactant
mammal
hyaline membrane
remedy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP6821179A
Other languages
English (en)
Japanese (ja)
Other versions
JPS619925B2 (enExample
Inventor
Tetsuo Fujiwara
Yuji Tanaka
Tsunetomo Takei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Tokyo Tanabe Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13367224&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPS55160721(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tokyo Tanabe Co Ltd filed Critical Tokyo Tanabe Co Ltd
Priority to JP6821179A priority Critical patent/JPS55160721A/ja
Priority to US06/152,048 priority patent/US4338301A/en
Priority to AU58678/80A priority patent/AU520543B2/en
Priority to FR8011680A priority patent/FR2457872A1/fr
Priority to CA000353105A priority patent/CA1161754A/en
Priority to DE3021006A priority patent/DE3021006C2/de
Priority to GB8017939A priority patent/GB2050832B/en
Publication of JPS55160721A publication Critical patent/JPS55160721A/ja
Publication of JPS619925B2 publication Critical patent/JPS619925B2/ja
Priority to MX9203482A priority patent/MX9203482A/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fats And Perfumes (AREA)
  • Steroid Compounds (AREA)
JP6821179A 1979-06-02 1979-06-02 Pulmonary surfactant ta-546, its preparation, and remedy for pulmonary hyaline membrane syndrome comprising it as active constituent Granted JPS55160721A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP6821179A JPS55160721A (en) 1979-06-02 1979-06-02 Pulmonary surfactant ta-546, its preparation, and remedy for pulmonary hyaline membrane syndrome comprising it as active constituent
US06/152,048 US4338301A (en) 1979-06-02 1980-05-21 Lung tissue extract useful for treating hyaline-membrane disease and method for producing the extract
AU58678/80A AU520543B2 (en) 1979-06-02 1980-05-22 Surface active material
FR8011680A FR2457872A1 (fr) 1979-06-02 1980-05-27 Procede de production de matieres tensio-actives, nouveaux produits ainsi obtenus et compositions pharmaceutiques pour le traitement de maladie de la membrane hyaline contenant ces matieres tensio-actives
DE3021006A DE3021006C2 (de) 1979-06-02 1980-05-30 Oberflächenaktives Material und dieses Material enthaltendes pharmazeutisches Mittel gegen Hyalin-Membran-Erkrankung
CA000353105A CA1161754A (en) 1979-06-02 1980-05-30 Surface active material, method for producing the same, and pharmaceutical composition for hyaline- membrane disease containing said material
GB8017939A GB2050832B (en) 1979-06-02 1980-06-02 Surface active material containing phospholipid lipid carbohydrate and protein
MX9203482A MX9203482A (es) 1979-06-02 1992-06-26 Surfactante pulmonar ta-546, proceso para preparacion del mismo y remedios para sindrome de tension respiratoria que contienen este surfactante como ingrediente activo.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6821179A JPS55160721A (en) 1979-06-02 1979-06-02 Pulmonary surfactant ta-546, its preparation, and remedy for pulmonary hyaline membrane syndrome comprising it as active constituent

Publications (2)

Publication Number Publication Date
JPS55160721A true JPS55160721A (en) 1980-12-13
JPS619925B2 JPS619925B2 (enExample) 1986-03-27

Family

ID=13367224

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6821179A Granted JPS55160721A (en) 1979-06-02 1979-06-02 Pulmonary surfactant ta-546, its preparation, and remedy for pulmonary hyaline membrane syndrome comprising it as active constituent

Country Status (8)

Country Link
US (1) US4338301A (enExample)
JP (1) JPS55160721A (enExample)
AU (1) AU520543B2 (enExample)
CA (1) CA1161754A (enExample)
DE (1) DE3021006C2 (enExample)
FR (1) FR2457872A1 (enExample)
GB (1) GB2050832B (enExample)
MX (1) MX9203482A (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5795920A (en) * 1980-12-04 1982-06-15 Teijin Ltd Remedy for respiratory disease
JPS60237023A (ja) * 1983-12-08 1985-11-25 アルツナイミッテルベルク、ドレスデン、ゲゼルシャフト、ミット、ベシュレンクテル、ハフツング 界面活性剤欠乏起因の呼吸困難症候群を治療するための薬剤およびその製造法
JPS6463526A (en) * 1987-04-08 1989-03-09 Chiesi Farma Spa Pulmonary artery surfactant, preparation and drug composition

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3228629A1 (de) * 1982-07-31 1984-02-02 Reifenrath, Rainer Richard Otto, Dr., 3104 Unterlüß Pharmazeutisches erzeugnis zur behandlung der atemwege und verfahren zu seiner herstellung
DE3229179C2 (de) * 1982-08-05 1986-04-17 A. Nattermann & Cie GmbH, 5000 Köln Lungensurfactant
JPS59164724A (ja) * 1983-03-10 1984-09-17 Tokyo Tanabe Co Ltd サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤
CS938384A1 (en) * 1983-12-08 1990-08-14 Lachmann Burkhardt Pharmaceutical agent for breathlesness therapy and method of its production
FR2559669B1 (fr) * 1984-02-20 1986-05-09 Nabavi Seyfeddine Lipoproteine haute densite cholesterol synthetique
IL71051A (en) * 1984-02-23 1988-02-29 Yeda Res & Dev Compositions containing active lipids for the treatment of cystic fibrosis
US5013720A (en) * 1986-05-06 1991-05-07 Abbott Laboratories SAP-6-Val proteins and methods
JPH01501282A (ja) * 1986-12-08 1989-05-11 ホイツトセツト，ジエフリー　エイ． 肺胞疎水性界面活性物質関連タンパク質
US4861756A (en) * 1988-03-08 1989-08-29 Merrell Dow Pharmaceuticals Inc. Synthetic pulmonary surfactant
AU3073789A (en) * 1988-03-31 1989-10-05 Abbott Laboratories Drug delivery using pulmonary surfactant to facilitate absorption
DE3921954A1 (de) * 1989-07-04 1991-01-17 Thomae Gmbh Dr K Niedrig-viskose, hochkonzentrierte surfactant-suspension
CO5021218A1 (es) * 1994-12-29 2001-03-27 Ct Nac De Sanidad Agropecuaria Surfactante pulmonar natural porcino
US6129934A (en) * 1995-06-07 2000-10-10 Ony, Inc. Modification of animal lung surfactant for treating respiratory disease due to lung surfactant deficiency or dysfunction
US6172203B1 (en) * 1996-02-07 2001-01-09 Alfredo Adolfo Hager Method for extracting and purifying pulmonary surfactant
EP0904295B1 (en) * 1996-05-15 2005-08-10 ALTANA Pharma AG Process for separating and analyzing hydrophobic proteins using thin layer chromatography
US6855342B2 (en) * 2000-06-30 2005-02-15 Medicis Pharmaceutical Corporation Compositions and methods for high sorption of skin materials and delivery of sulfur
US6514489B1 (en) 2000-06-30 2003-02-04 Medicis Pharmaceutical Corp. Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions
US20050025817A1 (en) * 2003-07-03 2005-02-03 Bhatia Kuljit S. Delivery system for topical medications
US7479289B2 (en) * 2004-07-02 2009-01-20 Medicis Pharmaceutical Corporation Stable cleanser compositions containing sulfur
US7582312B2 (en) * 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
GB0426010D0 (en) * 2004-11-26 2004-12-29 Britannia Pharmaceuticals Ltd Improvements in or relating to organic materials
US11219843B2 (en) * 2019-07-08 2022-01-11 Nik Paya Karen Pharmed Extraction of animal-derived pulmonary surfactants

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3594476A (en) * 1969-05-12 1971-07-20 Massachusetts Inst Technology Submicron aqueous aerosols containing lecithin

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5795920A (en) * 1980-12-04 1982-06-15 Teijin Ltd Remedy for respiratory disease
JPS60237023A (ja) * 1983-12-08 1985-11-25 アルツナイミッテルベルク、ドレスデン、ゲゼルシャフト、ミット、ベシュレンクテル、ハフツング 界面活性剤欠乏起因の呼吸困難症候群を治療するための薬剤およびその製造法
JPS6463526A (en) * 1987-04-08 1989-03-09 Chiesi Farma Spa Pulmonary artery surfactant, preparation and drug composition

Also Published As

Publication number Publication date
AU5867880A (en) 1981-12-10
FR2457872A1 (fr) 1980-12-26
FR2457872B1 (enExample) 1984-09-21
DE3021006C2 (de) 1983-03-17
MX9203482A (es) 1992-08-01
GB2050832A (en) 1981-01-14
DE3021006A1 (de) 1981-01-08
CA1161754A (en) 1984-02-07
GB2050832B (en) 1983-08-03
US4338301A (en) 1982-07-06
AU520543B2 (en) 1982-02-04
JPS619925B2 (enExample) 1986-03-27

Similar Documents

Publication Publication Date Title
JPS55160721A (en) Pulmonary surfactant ta-546, its preparation, and remedy for pulmonary hyaline membrane syndrome comprising it as active constituent
Beck et al. Vitamin E deficiency intensifies the myocardial injury of coxsackievirus B3 infection of mice
Kurokawa et al. Carcinogenicity of potassium bromate administered orally to F344 rats
Keyl et al. Aflatoxin effects in livestock
DE3886970D1 (de) Natürliches oberflächenwirksames Lungenpräparat, Verfahren zu seiner Herstellung und pharmazeutische Zusammensetzungen.
Reza Toxicological effect of formalin as food preservative on kidney and liver tissues in mice model
Porter et al. DDE at low dietary levels kills captive American kestrels
Green A skeletal difference between sublines of the C3H strain of mice
Aulerich et al. Biological effects of epidermal growth factor and 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin on developmental parameters of neonatal mink
Sadler Present evidence on the role of meat in the epidemiology of human brucellosis
ZA823133B (en) Preparations of fresh,chopped onions which may be dispensed from tubes
PT857017E (pt) Composicao para o tratamento das palhas dos aviarios
Ockerman et al. Influence of type (wooled or hair) and breed on growth and carcass characteristics and sensory properties of lamb
Jensen et al. Laryngeal contact ulcers in feedlot cattle
Mills Behavioural adaptations of brown and spotted hyaenas in the southern Kalahari.
Na et al. Decrease in spinal CGRP and substance P is not related to neuropathic pain in a rat model
Colloff et al. Haemorrhagic disease in cattle with genotype 1 bovine viral diarrhoea virus infection
Silverthorne et al. Observations on the Action of Human and Animal Blood on the Meningococcus
DE2611979A1 (de) Mittel zur behandlung von blaehungen und durchfall bei tieren
MacDonald et al. Growth of contagious pustular dermatitis virus in human tissue cultures
Gupta Spontaneous aortic atherosclerosis in cattle
Korschgen An evaluation of a new cooking method for shoulder clod and chuck roll roasts of beef
JPS56124342A (en) Method for improving taste of dairy product
Fumarola Endotoxin and coagulopathic disorders after ascitic fluid infusion
Wright et al. Biotransformation and deposition of residues of fenthion and oxidative metabolites in fat of cattle